Osteoboost

Founded: 2018 • Age: 8 yrs
Wearable device delivers targeted vibrations for low bone density therapy.

About Osteoboost

Osteoboost is a company founded in 2018 by Nikhil Viswanathan, Daniel Burnett, Michael Jaasma, and Shane Mangrum. Osteoboost has raised $8 million across 5 funding rounds from investors including HHS, Good Growth Capital and Terumo Medical Corporation. Osteoboost operates in a competitive market with competitors including Trice Medical, Edge Surgical, OrthoScan, Onicorp and Bone Index Finland, among others.

  • Founders Nikhil Viswanathan, Daniel Burnett, Michael Jaasma, Shane Mangrum
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website osteoboost.com
  • Social LinkedIn X
Operational Areas
Key Metrics
  • Total Equity Funding
    $8M (USD)

    in 5 rounds

  • Investors
    HHS

    & 12 more

Funding Insights of Osteoboost

Osteoboost has successfully raised a total of $8M across 5 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $8M
  • Total Rounds 5
  • First Round $2.71M

    (Jun 2018)

  • Investors Count 13

All 5 funding rounds of Osteoboost with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Apr 2026$8MSeries A–Ambit Health Ventures
Emmeline Ventures,Disrupt Technology Venture
Mar 2023$5MSeries A––
May 2021$2.5MSeed–Good Growth Capital
Aug 2019$504,999Seed––
–
Jun 2018$2.71MGrant––
Valuation history

13 investors in total: 13 institutional.

Investors in Osteoboost

Osteoboost has secured backing from 13 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, Good Growth Capital and Terumo Medical Corporation.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Healthcare startups are funded by Esplanade Ventures venture capital.
–esplanadeventures.comMontreal, Canada
-
–berkeleycatalystfund.com-
Early-stage investments are made in life sciences and technologies.
2017goodgrowthvc.comCharleston, United States
-
–ambithealthventures.com-
Venture capital firm creating funds for innovative companies in women's health and emerging markets.
–portfolia.co-
Tech & Life-Sciences focused VC Firm investing in the US
–goldenseeds.comNew York, United States
An angel investor network is formed by UC Berkeley affiliates.
2012berkeleyangelnetwork.comSan Francisco, United States
Early-stage investments are made in technology-enabled startups by Reno Seed Fund.
2019renoseedfund.comReno, United States
Early-stage tech investments are directed toward Asia and the US.
–it-farm.comShinjuku City, Japan
Angel investing in high-tech and life science startups since 1994.
–bandangels.com-
Premium access

Investor details for Osteoboost

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Osteoboost

5 people are tracked at Osteoboost (5 in leadership).

NameRoleGroup
Nikhil Viswanathan
FounderLeadership
Daniel Burnett
Founder & CEOLeadership
Michael Jaasma
Co-FounderLeadership
Shane Mangrum
Co-FounderLeadership
Laura Yecies
CEOLeadership
Premium access

Complete people profiles for Osteoboost

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Osteoboost

3 dated milestones of Osteoboost across 8 years, from founding to its latest funding, stage changes and deals.

  1. Founded Osteoboost is founded.
  2. Funding First funding round of $2.7M.
  3. Funding Latest funding round, Series A,.

Competitors of Osteoboost

Osteoboost operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Trice Medical, Edge Surgical, OrthoScan, Onicorp and Bone Index Finland, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
tricemedical.com2012King Of Prussia, United States$85.47M67
Needle-based visualization devices for orthopedic diagnostics are developed.
edgesurgical.com2015Chicago, United States$16.99M–
Digital depth gauges for orthopedic bone measurements are supplied.
orthoscan.com2002Scottsdale, United States$8.33M148
Mini C-arms for orthopedic imaging are developed by OrthoScan.
onicorp.com1997Boston, United States$28M–
MRI systems for extremity imaging are developed and marketed.
bindex.fi2011Kuopio, Finland––
Ultrasound-based POC device for osteoporosis screening is developed.
rossumrobot.cn2017Haidian, China$14.33M–
Robotic surgical systems for orthopedic treatments are provided.
echolightmedical.com2010Lecce, Italy$4.4M–
Radiation-free bone densitometers for osteoporosis assessment are developed.
activelifescientific.com2007Santa Barbara, United States$3.26M6
Bone and tissue quality measurement devices are developed.
genourob.com2007Laval, France$417,81222
Medical devices to measure knee ligament laxity and enhance rehabilitation
hemics.com2011Eindhoven, Netherlands––
Imaging devices for rheumatoid arthritis detection are developed by Hemics.
Premium access

Detailed competitors of Osteoboost

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Osteoboost

The website of Osteoboost (osteoboost.com) receives about 17.3K visits a month.

  • Monthly visits
    17.3K

    ▼ 3.3% vs previous month

Latest news on Osteoboost

Premium access

Complete news archive for Osteoboost

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Osteoboost

10 companies that operate in the same segment as Osteoboost (Orthopedics), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Provider of high-frequency spinal cord stimulation implants
2006Menlo Park, California, United StatesUSD 154.1 MUSD 353.08 M1,215
Prosthetic and orthotic devices are developed for individuals with disabilities.
1919Duderstadt, Lower Saxony, GermanyUSD 17 MUSD 1.97 B–
Developer of therapies for the treatment of musculoskeletal disorders
2007Woburn, Massachusetts, United StatesUSD 62 MUSD 85.55 M692
Developer of drugs for treating rare and autoimmune diseases
2008Dublin, IrelandUSD 61.78 MUSD 617.41 M–
Antibody-siRNA complexes are developed for cancer treatment.
2012San Diego, California, United StatesUSD 142.54 MUSD 10.9 M391
Smart surgical devices for spinal surgery are developed.
1997San Diego, California, United StatesUSD 54.1 M––
Robotic arms are provided for mobility and rehabilitation support.
2004Boston, Massachusetts, United StatesUSD 17.21 MUSD 40.93 M185
AI-powered drug discovery platform for various diseases
2016New York, New York, United StatesUSD 608 M––
Exoskeletons for medical rehabilitation and industrial productivity are provided.
2005United StatesUSD 24.37 MUSD 71.6 M61
Stabilization devices for healthcare are manufactured by the company.
2005New York, New York, United StatesUSD 142.15 M–43
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Osteoboost

Osteoboost was founded in 2018.

Daniel Burnett is the current CEO of Osteoboost. They have also founded this company.

Osteoboost is a funded company, having raised a total of $8M across 5 funding rounds to date. The company's 1st funding round was a Grant of $2.71M, raised on Jun 2018.

Osteoboost was founded in 2018 as a medical device company focused on non-pharmacological treatments for osteopenia in postmenopausal women. A wearable device is utilized to apply precise mechanical vibrations to the lumbar spine and hips, aiming to mitigate declines in bone strength and density. Operations center on developing and providing this patented therapy within the health technology sector.

Osteoboost's top competitors include Edge Surgical, Trice Medical and Echolight Medical.

Osteoboost has 13 investors. Key investors include HHS, Good Growth Capital, Terumo Medical Corporation, Esplanade Ventures, and Berkeley Catalyst Fund.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available